Author: Wang, Haofeng; Xue, Song; Yang, Haitao; Chen, Cheng
Title: Recent progress in the discovery of inhibitors targeting coronavirus proteases Cord-id: 5elel6qo Document date: 2016_2_19
ID: 5elel6qo
Snippet: Coronaviruses (CoVs) can cause highly prevalent diseases in humans and animals. The fatal outbreak of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) highlights the threat posed by this unique virus subfamily. However, no specific drugs have been approved to treat CoV-associated diseases to date. The CoV proteases, which play pivotal roles in viral gene expression and replication through a highly complex cascade involving the proteolytic processing of replica
Document: Coronaviruses (CoVs) can cause highly prevalent diseases in humans and animals. The fatal outbreak of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) highlights the threat posed by this unique virus subfamily. However, no specific drugs have been approved to treat CoV-associated diseases to date. The CoV proteases, which play pivotal roles in viral gene expression and replication through a highly complex cascade involving the proteolytic processing of replicase polyproteins, are attractive targets for drug design. This review summarizes the recent advances in biological and structural studies, together with the development of inhibitors targeting CoV proteases, particularly main proteases (M(pro)s), which could help develop effective treatments to prevent CoV infection. [Image: see text]
Search related documents:
Co phrase search for related documents- active site cleft and acute respiratory syndrome: 1, 2, 3, 4
- acute respiratory syndrome and liver histopathology: 1, 2, 3
- acute respiratory syndrome and lxgg consensus cleavage sequence: 1
Co phrase search for related documents, hyperlinks ordered by date